LogicBio Therapeutics (LOGC) Misses Q1 EPS by 27c
Tweet
Share
E-mailGet Alerts LOGC Hot Sheet
Price: $7.06 --0%
EPS Growth %: +42.9%
Financial Fact:
Gross margin: 151.4K
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +42.9%
Financial Fact:
Gross margin: 151.4K
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
LogicBio Therapeutics (NASDAQ: LOGC) reported Q1 EPS of ($0.27).
For earnings history and earnings-related data on LogicBio Therapeutics (LOGC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bessent: We Make A Market Buying Older Bonds
- Vishay launches 45 mm inductive encoder for industrial use
- Qualcomm (QCOM) call put ratio 4.8 calls to 1 put with a focus on September 11 weekly calls as share price up 4%
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
